1921
Volume 82, Issue 3
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

The purpose of this trial is to evaluate the clinical efficacy and cost/effectiveness of compared with yogurt fluid (YF) in acute non-bloody diarrhea in children. This randomized, prospective open-label clinical trial includes 55 children (36 boys, 19 girls; mean age 21.2 ± 28.2 months). Group A ( = 28) received lyophilized and group B ( = 27) received YF. The duration of diarrhea was shorter with but the hospital stay was reduced with YF, although these differences were not significant. However, diarrhea had resolved in significantly more children on day 3 in the group (48.5% versus 25.5%; < 0.05). In outpatient cases, yogurt treatment was cheaper than whereas in hospitalized patients, treatment cost was similar. In conclusion, the effect of daily freshly prepared YF was comparable to in the treatment of acute non-bloody diarrhea in children. The duration of diarrhea was shorter in the group, expressed as a significantly higher number of patients with normal stools on day 3.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.2010.09-0529
2010-03-01
2017-11-20
Loading full text...

Full text loading...

/deliver/fulltext/14761645/82/3/488.html?itemId=/content/journals/10.4269/ajtmh.2010.09-0529&mimeType=html&fmt=ahah

References

  1. Kosek M, Bern C, Guerrant RL, , 2003. The global burden of diarrhoeal disease, as estimated from studies published between 1992 and 2000. Bull World Health Organ 81: 197204.
  2. Sazawal S, Dhingra U, Dhingra P, Hiremath G, Kumar J, Sarkar A, Menon VP, Black RE, , 2006. Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. Lancet Infect Dis 6: 374382.[Crossref]
  3. Guarino A, Albano F, Ashkenazi S, Gendrel D, Hoekstra JH, Shamir R, Szajewska H, , 2008. European Society for Paediatric Gastroenterology, Hepatology, and Nutrition/European Society for Paediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe. J Pediatr Gastroenterol Nutr 46: (Suppl 2): S81S122.
  4. Vandenplas Y, Salvatore S, Viera M, Devreker T, Hauser B, , 2007. Probiotics in infectious diarrhoea in children: are they indicated? Eur J Pediatr 166: 12111218.[Crossref]
  5. Vandenplas Y, Brunser O, Szajewska H, , 2009. Saccharomyces boulardii in childhood. Eur J Pediatr 168: 253265.[Crossref]
  6. Adolfsson O, Meydani SN, Russell RM, , 2004. Yogurt and gut function. Am J Clin Nutr 80: 245256.
  7. Veereman-Wauters G, Taminiau J, Wyllie R, Hyams JS, , 2006. Diarrhea. , eds. Pediatric Gastrointestinal and Liver Disease, Third edition. Philadelphia: Elsevier Inc., 151167.[Crossref]
  8. Waterlow JC, , 1972. Classification and definition of protein-calorie malnutrition. BMJ 3: 566569.[Crossref]
  9. Greenbaum L, Kliegman RM, Berman RE, Jenson HB, Stanton BF, , 2008. Deficit therapy. , eds. Nelson Textbook of Pediatrics, 18th edition. Philadelphia: Saunders Elsevier, 313316.
  10. Canani RB, Ruotolo S, , 2006. The dawning of the “zinc era” in the treatment of pediatric acute gastroenteritis worldwide? J Pediatr Gastroenterol Nutr 42: 253255.[Crossref]
  11. Lewis SJ, Heaton KW, , 1997. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol 32: 920924.[Crossref]
  12. Dinleyici EC, Eren M, Yargic ZA, Dogan N, Vandenplas Y, , 2009. Clinical efficacy of Saccharomyces boulardii and metronidazole compared to metronidazole alone in children with acute bloody diarrhea caused by amebiasis: a prospective, randomized, open label study. Am J Trop Med Hyg 80: 953955.
  13. Conway S, Hart A, Clark A, Harvey I, , 2007. Does eating yogurt prevent antibiotic-associated diarrhoea? A placebo-controlled randomised controlled trial in general practice. Br J Gen Pract 57: 953959.[Crossref]
  14. Gueimonde M, Delgado S, Mayo B, , 2004. Viability and diversity of probiotic Lactobacillus and Bifidobacterium populations included in commercial fermented milks. Food Res Int 37: 839850.[Crossref]
  15. Canani RB, Cirillo P, Terrin G, Cesarano L, Spagnuolo MI, De Vincenzo A, Albano F, Passariello A, De Marco G, Manguso F, Guarino A, , 2007. Probiotics for treatment of acute diarrhoea in children: randomised clinical trial of five different preparations. BMJ 335: 340.[Crossref]
  16. Guandalini S, , 2006. Probiotics for children: use in diarrhea. J Clin Gastroenterol 40: 244248.[Crossref]
  17. Pashapour N, Iou SG, , 2006. Evaluation of yogurt effect on acute diarrhea in 6–24-month-old hospitalized infants. Turk J Pediatr 48: 115118.
  18. Boudraa G, Benbouabdellah M, Hachelaf W, Boisset M, Desjeux JF, Touhami M, , 2001. Effect of feeding yogurt versus milk in children with acute diarrhea and carbohydrate malabsorption. J Pediatr Gastroenterol Nutr 33: 307313.[Crossref]
  19. Van Niel CW, Feudtner C, Garrison MM, Chrisatkis DA, , 2002. Review: Lactobacillus is safe and effective for treating children with acute infectious diarrhea. Pediatrics 109: 678684.[Crossref]
  20. Billoo AG, Memon MA, Khaskheli SA, Murtaza G, Iqbal K, Saeed Shekhani M, Siddiqi AQ, , 2006. Role of a probiotic (Saccharomyces boulardii) in management and prevention of diarrhoea. World J Gastroenterol 12: 45574560.[Crossref]
  21. Htwe K, Yee KS, Tin M, Vandenplas Y, , 2008. Effect of Saccharomyces boulardii in the treatment of acute watery diarrhea in Myanmar children: a randomized controlled study. Am J Trop Med Hyg 78: 214216.
  22. Kurugol Z, Koturoğlu G, , 2005. Effects of Saccharomyces boulardii in children with acute diarrhoea. Acta Paediatr 94: 4447.[Crossref]
  23. Szajewska H, Skorka A, Dyla GM, , 2007. Meta-analysis: Saccharomyces boulardii for treating acute diarrhoea in children. Aliment Pharmacol Ther 25: 257264.[Crossref]
  24. Gaón D, García H, Winter L, Rodriguez N, Ouintas R, Gonzalez SN, Oliver G, , 2003. Effect of Lactobacillus strains and Saccharomyces boulardii on persistent diarrhea in children. Medicina (B Aires) 63: 293298.
  25. Burkhardt O, Köhnlein T, Pletz M, Welte T, , 2005. Saccharomyces boulardii induced sepsis: successful therapy with voriconazole after treatment failure with fluconazole. Scand J Infect Dis 37: 6972.[Crossref]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2010.09-0529
Loading
/content/journals/10.4269/ajtmh.2010.09-0529
Loading

Data & Media loading...

  • Received : 07 Sep 2009
  • Accepted : 21 Nov 2009

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error